Abstract
Background
Chronic subdural haematoma is a common but retractable neurological disease in the elderly with a high rate of recurrence. Dexamethasone (DX) either as monotherapy or adjuvant therapy has been applied clinically, but its effectiveness and feasibility remain controversial. We conducted this review to clarify this issue.
Methods
With a systematic review through multiple databases, we retrieved eligible English language publications and extracted relevant data to perform meta-analyses. The respective risk ratio (RR) and its 95% confidence interval (CI) were pooled to evaluate the overall effect.
Results
Our meta-analysis showed overall that DX (alone or adjuvant) resulted in a lower recurrence rate when compared with non-DX therapy (RR, 0.54; 95% CI, 0.33-0.88; p = 0.01), but sensitivity analysis by excluding the most influential study achieved inconsistent results. The pooled effect revealed no statistical difference on recurrence rate between DX alone and non-DX therapy or surgical therapy (RR, 0.86; 95% CI, 0.43-1.71; p = 0.66) (RR, 0.89; 95% CI, 0.43-1.85; p = 0.76). Comparison between DX alone with the surgical therapy demonstrated no difference on the poor outcome (RR, 0.40; 95% CI, 0.15-1.04; p = 0.06).
Conclusions
We had no enough evidence to support DX use as an effective alternation to surgical therapy. But adjuvant DX use may facilitate the surgical therapy by reducing recurrence. Further study focusing on adjuvant DX was required.
Similar content being viewed by others
References
Adhiyaman V, Asghar M, Ganeshram KN, Bhowmick BK (2002) Chronic subdural haematoma in the elderly. Postgrad Med J 78:71-75
Almenawer SA, Farrokhyar F, Hong C, Alhazzani W, Manoranjan B, Yarascavitch B, Arjmand P, Baronia B, Reddy K, Murty N, Singh S (2014) Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 259:449–457
Ambrosetto C (1962) Post-traumatic subdural hematoma—further observations on nonsurgical treatment. Arch Neurol 6:287–292
Asghar M, Adhiyaman V, Greenway MW, Bhowmick BK, Bates A (2002) Chronic subdural haematoma in the elderly—a North Wales experience. J Roy Soc Med 95:290–292
Bae ME, Wessling H, Salca HC, Echeverria PD (2011) Use of twist-drill craniostomy with drain in evacuation of chronic subdural hematomas: independent predictors of recurrence. Acta Neurochir 153:1097–1103
Bender MB, Christoff N (1974) Nonsurgical treatment of subdural hematomas. Arch Neurol 31:73–79
Berghauser Pont LM, Dammers R, Schouten JW, Lingsma HF, Dirven CM (2012) Clinical factors associated with outcome in chronic subdural hematoma: a retrospective cohort study of patients on preoperative corticosteroid therapy. Neurosurgery 70:873–880 discussion 880
Berghauser Pont LM, Dirven CM, Dippel DW, Verweij BH, Dammers R (2012) The role of corticosteroids in the management of chronic subdural hematoma: a systematic review. Eur J Neurol 19:1397–1403
Cousseau D, Echevarria G, Gaspari M, Gonorazky SE (2001) Chronic and subacute subdural haematoma. An epidemiological study in a captive population. Rev Neurol 32:821–824
Delgado-Lopez PD, Martin-Velasco V, Castilla-Diez JM, Rodriguez-Salazar A, Galacho-Harriero AM, Fernandez-Arconada O (2009) Dexamethasone treatment in chronic subdural haematoma. Neurocirugia (Astur) 20:346–359
Dran G, Berthier F, Fontaine D, Rasenrarijao D, Paquis P (2007) Effectiveness of adjuvant corticosteroid therapy for chronic subdural hematoma: a retrospective study of 198 cases. Neurochirurgie 53:477–482
Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ (2017) Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 14:108
Gazzeri R, Galarza M, Neroni M, Canova A, Refice GM, Esposito S (2007) Continuous subgaleal suction drainage for the treatment of chronic subdural haematoma. Acta Neurochir 149:487–493 discussion 493
Glover D, Labadie EL (1976) Physiopathogenesis of subdural hematomas. 2. Inhibition of growth of experimental hematomas with dexamethasone. J Neurosurg 45:393–397
Hennig R, Kloster R (1999) Burr hole evacuation of chronic subdural haematomas followed by continuous inflow and outflow irrigation. Acta Neurochir 141:171–176
Hong HJ, Kim YJ, Yi HJ, Ko Y, Oh SJ, Kim JM (2009) Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. Surg Neurol 71:161–165 discussion 165-166
Ito H, Komai T, Yamamoto S (1978) Fibrinolytic enzyme in the lining walls of chronic subdural hematoma. J Neurosurg 48:197–200
Khadka NK, Sharma GR, Roka YB, Kumar P, Bista P, Adhikari D, Devkota UP (2008) Single burr hole drainage for chronic subdural haematoma. Nepal Med Coll J 10:254–257
Kolias AG, Chari A, Santarius T, Hutchinson PJ (2014) Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 10:570–578
Kudo H, Kuwamura K, Izawa I, Sawa H, Tamaki N (1992) Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect. Neurol Med Chir (Tokyo) 32:207–209
Labadie EL, Glover D (1975) Local alterations of hemostatic-fibrinolytic mechanisms in reforming subdural hematomas. Neurology 25:669–675
Markwalder TM, Steinsiepe KF, Rohner M, Reichenbach W, Markwalder H (1981) The course of chronic subdural hematomas after burr-hole craniostomy and closed-system drainage. J Neurosurg 55:390–396
Nakaguchi H, Tanishima T, Yoshimasu N (2001) Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg 95:256–262
Pichert G, Henn V (1987) Conservative therapy of chronic subdural hematomas. Schweiz Med Wochenschr 117:1856–1862
Prud’homme M, Mathieu F, Marcotte N, Cottin S (2016) A pilot placebo controlled randomized trial of dexamethasone for chronic subdural hematoma. Can J Neurol Sci 43:284–290
Qian Z, Yang D, Sun F, Sun Z (2017) Risk factors for recurrence of chronic subdural hematoma after burr hole surgery: potential protective role of dexamethasone. Br J Neurosurg 31:84–88
Santarius T, Lawton R, Kirkpatrick PJ, Hutchinson PJ (2008) The management of primary chronic subdural haematoma: a questionnaire survey of practice in the United Kingdom and the Republic of Ireland. Br J Neurosurg 22:529–534
Stanisic M, Lyngstadaas SP, Pripp AH, Aasen AO, Lindegaard KF, Ivanovic J, Ilstad E, Konglund A, Sandell T, Ellingsen O, Saehle T (2012) Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study. Acta Neurochir 154:113–120
Sun TFD, Boet R, Poon WS (2005) Non-surgical primary treatment of chronic subdural haematoma: preliminary results of using dexamethasone. Brit J Neurosurg 19:327–333
Zhang Y, Chen S, Xiao Y, Tang W (2017) Effects of dexamethasone in the treatment of recurrent chronic subdural hematoma. World Neurosurg. https://doi.org/10.1016/j.wneu.2017.05.135
Funding
This work was funded by Science and Technology Supportive Project of Sichuan Province (No. 2015SZ0051) and 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (No. ZY2016102).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None
Ethical statements
This review required no ethical approval.
Rights and permissions
About this article
Cite this article
Yao, Z., Hu, X., Ma, L. et al. Dexamethasone for chronic subdural haematoma: a systematic review and meta-analysis. Acta Neurochir 159, 2037–2044 (2017). https://doi.org/10.1007/s00701-017-3309-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-017-3309-7